Literature DB >> 494398

Time dependence of hematoporphyrin distribution in selected tissues of normal rats and in ascites hepatoma.

G Jori, G Pizzi, E Reddi, L Tomio, B Salvato, P Zorat, F Calzavara.   

Abstract

The distribution of hematoporphyrin was determined in normal rats and in rats bearing ascites hepatoma as a function of time after i.p. injection of 10-20 mg/kg of dye. In both cases, hematoporphyrin displayed a high affinity for the tumor cells. At 20 mg/kg, the maximum difference between the amount of hematoporphyrin accumulated in the tumor and in the liver was obtained at 12 h after injection (tumor/liver ratio = 28). Our results suggest that hematoporphyrin is almost exclusively metabolized in the liver and excreted via the biliary tract, whereas only minor amounts are metabolized in the tumor cells. Moreover, the binding between the porphyrin and tumor cells is competitive with serum protein binding.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 494398     DOI: 10.1177/030089167906500402

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  6 in total

Review 1.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 2.  Phototherapy in tumors.

Authors:  S G Bown
Journal:  World J Surg       Date:  1983-11       Impact factor: 3.352

3.  Hematoporphyrin uptake by experimentally induced cholesteatomas in an animal model.

Authors:  G P Teatini; C Perria; G Iori; F Meloni; F Tanda
Journal:  Arch Otorhinolaryngol       Date:  1989

4.  Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics.

Authors:  Leanne B Josefsen; Ross W Boyle
Journal:  Theranostics       Date:  2012-10-04       Impact factor: 11.556

5.  Controlled targeting of different subcellular sites by porphyrins in tumour-bearing mice.

Authors:  G Jori; E Reddi; I Cozzani; L Tomio
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

6.  Preferential delivery of liposome-incorporated porphyrins to neoplastic cells in tumour-bearing rats.

Authors:  G Jori; L Tomio; E Reddi; E Rossi; L Corti; P L Zorat; F Calzavara
Journal:  Br J Cancer       Date:  1983-08       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.